Bibliografia
1. Uzal F.A., Songer J.G. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 2008; vol. 20, n. 3, pp. 253–265. doi: 10.1177/104063870802000301.
2. Petit L., Gibert M., Popoff M.R. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999; vol. 7, n. 3, pp. 104–110. doi: 10.1016/s0966-842x(98)01430-9.
3. Valente C., Cuteri V. In: Malattie infettive degli animali domestici ad eziologia batterica. Ed. Nisroch, Macerata, 2021; pp. 23-63.
4. Deprez P. Clostridium perfringens infections - a diagnostic challenge. Vet. Rec. 2015; vol. 177, n. 15, pp. 388–389. doi: 10.1136/vr.h5428.
5. Bueschel D.M., Jost B.H., Billington S.J. Prevalence of cpb2, encoding beta2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet. Microbiol. 2003; vol. 94, n. 2, pp. 121–129. doi: 10.1016/s0378-1135(03)00081-6.
6. Garmory H.S., Chanter N., French N.P. Occurrence of Clostridium perfringens beta2-toxin amongst animals, determined using genotyping and subtyping PCR assays. Epidemiol. Infect. 2000; vol. 124, n. 1, pp. 61–67. doi: 10.1017/s0950268899003295.
7. Goossens E., Valgaeren B.R., Pardon B. Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis. Vet. Res. 2017; vol. 48, n 1, pp. 9. doi: 10.1186/s13567-017-0413-x.
8. Tweten R.K. Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet. Microbiol. 2001; vol. 82, n. 1, pp. 1-9. doi: 10.1016/s0378-1135(01)00372-8.
9. Rood J.I. Virulence genes of Clostridium perfringens. Ann. Rev. Microbiol. 1998; vol. 52, pp. 333–360. doi: 10.1146/annurev.micro.52.1.333.
10. Alves G.G., Machado de Avila R.A., Chavez-Olortegui C.D. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known. Anaerobe. 2014; vol. 30, pp. 102–107. doi: 10.1016/j.anaerobe.2014.08.016.
11. Greco G., Madio A., Buonavoglia D. Clostridium perfringens toxin-types in lambs and kids affected with gastroenteric pathologies in Italy. Vet. J. 2005; vol. 170, n. 3, pp. 346–350. doi: 10.1016/j.tvjl.2004.08.001.
12. Freedman J.C., Shrestha A., McClane B.A. Clostridium perfringens enterotoxin: action, genetics, and translational applications. Toxins (Basel) 2016; vol. 8, n. 3 doi: 10.3390/toxins8030073.
13. Schotte U., Truyen U., Neubauer H. Significance of beta 2-toxigenic Clostridium perfringens infections in animals and their predisposing factors–a review. J. Vet. Med. B Infect. Dis. Vet. Public Health. 2004; vol. 51, n. 10, pp. 423–426. doi: 10.1111/j.1439-0450.2004.00802.x.
14. Gkiourtzidis K., Frey J., Bourtzi-Hatzopoulou E. PCR detection and prevalence of alpha-, beta-, beta 2-, epsilon-, iota- and enterotoxin genes in Clostridium perfringens isolated from lambs with clostridial dysentery. Vet. Microbiol. 2001; vol. 82, n. 1, pp. 39–43. doi: 10.1016/s0378-1135(01)00327-3.
15. Gohari I.M., Parreira V.R., Timoney J.F. NetF-positive Clostridium perfringens in neonatal foal necrotising enteritis in Kentucky. Vet. Rec. 2016; vol. 178, n. 9, pp. 216. doi: 10.1136/vr.103606.
16. Gohari I.M., Unterer S., Whitehead A.E., Prescott J.F. NetF-producing Clostridium perfringens and its associated diseases in dogs and foals. J. Vet. Diagn. Invest. 2020; vol. 32, n. 2, pp. 230-238. doi: 10.1177/1040638720904714.
17. Keyburn A.L., Yan X.X., Bannam T.L. Association between avian necrotic enteritis and Clostridium perfringens strains expressing NetB toxin. Vet. Res. 2010; vol. 41, n. 2, pp. 21. doi: 10.1051/vetres/2009069.
18. Schlegel B.J., Nowell V.J., Parreira V.R. Toxin-associated and other genes in Clostridium perfringens type A isolates from bovine clostridial abomasitis (BCA) and jejunal hemorrhage syndrome (JHS). Can. J. Vet. Res. 2012; vol. 76, n. 4, pp. 248–254.
19. Quinn P.J., Markey B.K., Leonard F.C., Hartigan P., Fanning S., Fitzpatrick E. S. In: Veterinary Microbiology and Microbial Disease. 2nd Ed., Wiley-Blackwell, 2011; pp. 233-249.
20. Smith B.P. In: Large Animal Internal Medicine. 6th Ed., Elsevier-Mosby, 2019.
21. Radostits O.M., Gay C.C., Hinchcliff K.W., Constable P.D. In: Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs, and Goats. Elsevier, 2007.
22. Merck Veterinary Manual. "Clostridial Diseases." https://www.merckvetmanual.com. Ultimo accesso: 07/01/2025.
TORNA INDIETRO
Eradicazione di M. hyopneumoniae nel suino: gli strumenti ci sono
I metodi storicamente impiegati per ridurre l’incidenza delle infezioni da M. hyopneumoniae non sembrano attualmente funzionare adeguatamente. I programmi di controllo per questo microrganismo si dividono in due macrocategorie: i programmi che prevedono l’eradicazione dell’agente patogeno e quelli che non la prevedono; a quest’ultima categoria appartengono le strategie che si basano su tre concetti: gestione, prevenzione e trattamento.
